INS and Hyperglycemia: For T1D, insulin is the primary treatment and is also indicated for patients with T2D diabetes who experience severe hyperglycemia (HbA1c > 10%), including a fasting glucose level greater than 250 mg/dL, which indicates glucose toxicity, in surgery to regulate glucose or during a hospitalization when oral medications are recommended to be discontinued and insulin becomes the preferred treatment.